BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220524T110000
DTEND;TZID=Europe/Stockholm:20220524T115000
DTSTAMP:20260403T205055
CREATED:20220520T144620Z
LAST-MODIFIED:20220520T145411Z
UID:79229-1653390000-1653393000@www.scilifelab.se
SUMMARY:SciLifeLab Uppsala PhD&Postdoc seminar
DESCRIPTION:Welcome to SciLifeLab Uppsala PhD&Postdoc seminars! \nWe are very happy to host exciting talks by PhD students and Postdocs from a great variety of fields within SciLifeLab. \n\n \n\n\n\nSpeaker 1: Hongxing Zhao\, Researcher at Ulf Landegren Lab (Molecular Tools)\, Dept. of Immunology\, Genetics and Pathology\n\n\n\nTitle: Detection of SARS-CoV-2 antibodies from dried blood spots of vaccine individuals by proximity extension assay Summary: We have developed a solution-phase assay for sensitive detection of SARS-CoV-2 antibodies in serum or dried blood spots (DBS) from infected or vaccinated individuals. Detection probes were prepared by conjugating the recombinant S1-RBD or nucleocapsid (NC) to either of a pair of oligonucleotides. Upon incubation with COVID-19 patient serum or DBS from vaccinated individuals\, the multivalency of the antibodies brings pairs of oligonucleotides that have been conjugated to the viral proteins in proximity. The oligonucleotides can then undergo enzymatic DNA extension via a proximity extension assay (PEA)\, and the resulting amplicons are sensitively detected by real-time PCR or end-point read out using ELISA mechine. This antibody PEA (AbPEA) test uses only 1 µl neat or diluted serum or one ø1.2 mm disc cut from a DBS. All 100 investigated sera and 21 DBS collected prior to the COVID-19 outbreak were negative\, demonstrating a 100% specificity. The sensitivity of the assay for infected patient after 10 days symptom reached 99.8% [95% confidence interval: 0.9935-1]. Anti-S1 antibodies could be detected directly in punched-out discs from self-sampled DBS 11 days after vaccination\, and it reached a maximum at 3 weeks after a first inoculation. Examination of a serially collected DBS from 14 individuals all showed similar trends of antibody responses after both a first and second vaccination\, although antibody levels varied between individuals. \n\n\n\nSpeaker 2: Manon Dubol\, PhD. Postdoctoral Researcher at Erika Comasco Neuropsychopharmacology Group\, Dept. of Women and Children’s Health\n\n\n\n\n\n\n\nTitle: Grey matter morphometry and MRI data-driven classification of premenstrual dysphoric disorder (PMDD) Summary: Premenstrual dysphoric disorder (PMDD) is recognized in the DSM-5 as a hormone-related depressive disorder\, specific to women’s mental health 1. Women who suffer from PMDD experience affective\, cognitive\, and physical symptoms that peak during the late luteal phase of the menstrual cycle\, and remit shortly in the beginning of the next cycle 2. The key affective symptoms of PMDD point to anatomical and functional brain impairment\, suggesting an impaired top-down inhibitory process involving limbic brain structures 3. However\, very little is known about brain morphological alterations in PMDD. The present study aimed at investigating the grey matter structures that distinguish women with PMDD from healthy controls\, by use of multiscale structural MRI analyses. Differences in grey matter structure between the groups were investigated by use of Voxel- and Surface Based Morphometry. Furthermore\, machine learning and multivariate pattern analysis was performed using a leave-one-fold-out cross-validation procedure\, to test whether MRI measures (volume\, thickness\, gyrification\, sulcal depth and cortical complexity) could distinguish women with PMDD from healthy controls. The findings point to PMDD-specific grey matter structure in regions of corticolimbic networks\, in line with the hypothesis of an impaired top-down inhibitory circuit involving limbic structures in PMDD. Furthermore\, the results include widespread cortical regions and cerebellar areas\, suggesting the involvement of distinct networks in PMDD pathophysiology. These effects prominently involved volumetric and cortical thickness measures\, as further highlighted by multivariate pattern classification analyses. Such differences in brain structure may help explaining the variations in brain function previously reported in women with PMDD during the symptomatic phase.
URL:https://www.scilifelab.se/event/scilifelab-uppsala-phdpostdoc-seminar/
LOCATION:Online event via Zoom
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/05/SciLifeLab-PhDPostdoc-conuncil-poster_landscape_May_24.png
END:VEVENT
END:VCALENDAR